{{Rsnum
|rsid=11568131
|Gene=ALOX15
|Chromosome=17
|position=4631313
|Orientation=minus
|GMAF=0.07392
|Gene_s=ALOX15
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 77.9 | 19.5 | 2.7
| HCB | 99.3 | 0.7 | 0.0
| JPT | 99.1 | 0.9 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 99.3 | 0.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 85.0 | 15.0 | 0.0
| LWK | 98.2 | 1.8 | 0.0
| MEX | 81.0 | 17.2 | 1.7
| MKK | 91.7 | 8.3 | 0.0
| TSI | 73.5 | 24.5 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22678777
|Title=PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer
|OA=1
}}

{{PMID|19942621|OA=1
}} An integrated expression phenotype mapping approach defines common variants in LEP, ALOX15 and CAPNS1 associated with induction of IL-6.

{{on chip | Illumina Human 1M}}